Oxaliplatin aggravates hepatic oxidative stress, inflammation and fibrosis in a non‑alcoholic fatty liver disease mouse model.

There was also a modest increase in α-smooth muscle actin (SMA) and tissue inhibitor of metallopeptidase (TIMP)-1 expression 6 days after administration of the first dose of OXA, but these differences did not reach statistical significance ( Fig. 5D and E ).

also in 111,027 other papers